Integrative therapies for children with hematological malignancies

Area of Science:

• Pediatric Oncology
• Integrative Medicine
• Hematological Malignancies

Background:

• Evidence for integrative therapies (IT) in pediatric hematological malignancies is developing.
• Integrative pediatric oncology aims to combine IT with conventional treatments safely and effectively.
• Potential interactions necessitate caution with herbs and supplements during active cancer therapy.

Purpose of the Study:

• To review the evolving evidence for integrative therapies in children with hematological malignancies.
• To emphasize the importance of safety and efficacy when integrating IT with conventional pediatric cancer care.
• To highlight the role of IT in promoting health and preventing disease in childhood cancer survivors.

Main Methods:

• Review of current literature on integrative therapies in pediatric hematological malignancies.
• Analysis of safety considerations, particularly regarding herb-drug interactions.
• Discussion of the role of IT in health promotion and survivorship.

Main Results:

• Evidence for IT in pediatric hematological malignancies is emerging but requires cautious application.
• Herbs and dietary supplements warrant careful use due to potential interactions during active treatment.
• IT can support health promotion and disease prevention strategies for survivors.

Conclusions:

• Integrative therapies can complement conventional pediatric oncology, focusing on health and wellness.
• Careful documentation of all IT use, responses, and effects is essential.
• Healthcare providers should support patients' active participation in healing through IT, fostering a collaborative approach.